Mann Brenda 4
4 · EYEGATE PHARMACEUTICALS INC · Filed Jul 6, 2021
Insider Transaction Report
Form 4
Mann Brenda
VP of Research & Development
Transactions
- Tax Payment
Common Stock
2021-07-02$3.70/sh−154$570→ 15,384 total
Footnotes (1)
- [F1]Sale of shares to cover taxes due on restricted stock that vested on 07/01/2021.